Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04538261
Other study ID # 1379199
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date November 1, 2020
Est. completion date January 31, 2023

Study information

Verified date February 2023
Source AdventHealth
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized double-blind clinical trial evaluating the effect of a balloon device (Fetal Pillow) to elevate the fetal buttocks during external cephalic version procedures. Eligible study population: nulliparous pregnant women between 37-40 weeks estimated gestational age with a breech presenting fetus and no contraindications to external cephalic version.


Description:

Patients meeting inclusion criteria will be offered participation in this study. After performing an obstetric sonogram to determine fetal position, amniotic fluid status, fetal weight and placental location, the patient will be randomized to either placement of the Fetal Pillow balloon device with sham inflation (control arm) or placement of the device with inflation (study arm). The researcher will show the patient the device, open the sterile container, and insert the device into the vagina per manufacturer's guidelines for all patients in the study. All patients will mark a line on a 100mm VAS to assess pre-insertion and post-insertion pain. The study physician will then obtain the assistance of a certified nurse midwife to inflate the device or perform a sham inflation. In order for the physician investigator to remain blinded, the physician will leave the room during the time of the inflation/sham inflation. A certified nurse midwife previously trained to inflate the device will perform the inflation or sham inflation per randomization. The assisting midwife will inflate the device with 180 mL of saline for those patients randomized to inflation. This will occur under a sheet so that the patient is blinded to the randomization scheme. If the patient is randomized to no inflation, the midwife will perform a sham inflation, also under a sheet. All patients will mark a line on a 100mm VAS to assess post-inflation/sham inflation pain. The assisting midwife then leaves the room, and the study physician reenters the room and proceeds with the external cephalic version (ECV) procedure. Regardless of randomization, at this point the ECV procedure proceeds using normal routine. The ECV will be attempted up to four times and VAS will be assessed after each attempt. Once completed, all patients will also mark a line on a 100mm VAS to assess post-ECV pain. The research physician will then remove the Fetal Pillow. Regardless of randomization, the procedure is completed per the usual routine of fetal monitoring, assessing for rupture of membranes, labor or bleeding, discussing post-procedure care, then discharge home (or, less likely, admitting for either observation or delivery). The researcher will fill out the ECV portion of the data collection form. Data are collected later for delivery outcomes and costs for the mother and neonate.


Recruitment information / eligibility

Status Terminated
Enrollment 11
Est. completion date January 31, 2023
Est. primary completion date January 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Women delivering at AdventHealth Orlando campus. 2. Breech presenting part as diagnosed by bedside sonography. 3. No prior deliveries >/= 20 weeks gestational age. 4. Pregnancy is between 37-40 weeks gestational age. 5. Live fetus. 6. Patient is >/= age 18. 7. Patient speaks English or Spanish as primary language. 8. Patient able to understand verbal and written consent Exclusion Criteria: 1. Non-breech presentation (cephalic, transverse, oblique). 2. More than 1 fetus. 3. Cervical dilation of >/= 1cm. 4. Prior uterine incision. 5. Congenital uterine anomaly. 6. Body mass index more than 40 kg/m2. 7. Uterine fibroids causing soft tissue dystocia. 8. Extended fetal neck. 9. Oligohydramnios (4-quadrant amniotic fluid index </= 5cm). 10. Spontaneous rupture of membranes. 11. Any contraindication to vaginal delivery. 12. Intrauterine growth restriction (estimated fetal weight </= 10%ile). 13. Estimated fetal weight > /= 5,000 grams for non-diabetic patient or >/= 4,500 grams for patient with pre-existing or gestational diabetes, confirmed by ultrasound. 14. Fetal gastroschisis. 15. Fetal neural tube defect. 16. Severe-range preeclampsia. 17. Patient had regional anesthesia immediately prior to ECV.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Fetal Pillow insertion
Inflation of balloon device used to elevate fetal buttocks prior to performing external cephalic version procedure

Locations

Country Name City State
United States AdventHealth Orlando Orlando Florida

Sponsors (1)

Lead Sponsor Collaborator
AdventHealth

Country where clinical trial is conducted

United States, 

References & Publications (5)

External Cephalic Version: ACOG Practice Bulletin, Number 221. Obstet Gynecol. 2020 May;135(5):e203-e212. doi: 10.1097/AOG.0000000000003837. — View Citation

Hofmeyr GJ, Kulier R, West HM. External cephalic version for breech presentation at term. Cochrane Database Syst Rev. 2015 Apr 1;2015(4):CD000083. doi: 10.1002/14651858.CD000083.pub3. — View Citation

Kok M, Cnossen J, Gravendeel L, van der Post J, Opmeer B, Mol BW. Clinical factors to predict the outcome of external cephalic version: a metaanalysis. Am J Obstet Gynecol. 2008 Dec;199(6):630.e1-7; discussion e1-5. doi: 10.1016/j.ajog.2008.03.008. Epub 2 — View Citation

Seal SL, Dey A, Barman SC, Kamilya G, Mukherji J, Onwude JL. Randomized controlled trial of elevation of the fetal head with a fetal pillow during cesarean delivery at full cervical dilatation. Int J Gynaecol Obstet. 2016 May;133(2):178-82. doi: 10.1016/j — View Citation

Weiniger CF, Ginosar Y, Elchalal U, Sharon E, Nokrian M, Ezra Y. External cephalic version for breech presentation with or without spinal analgesia in nulliparous women at term: a randomized controlled trial. Obstet Gynecol. 2007 Dec;110(6):1343-50. doi: — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Successful external cephalic version Successful conversion of breech fetus to cephalic presentation Immediately upon completion of the ECV procedure
Secondary Cesarean delivery Presence of cesarean delivery Immediately after ECV procedure or during subsequent labor and delivery
Secondary Fetal presentation at time of delivery Presentation of the fetus during participant delivery Labor and Delivery (approximately 12 hours)
Secondary Cost of ECV procedure and hospital stay (mother) Total cost of hospital stay for mother ECV procedure and during labor, delivery, and immediate postpartum period (up to 42 days)
Secondary Cost of ECV procedure and hospital stay (neonate) Cost of neonate's hospitalization after delivery Birth to hospital discharge (up to 42 days)
Secondary Shoulder dystocia Presence of shoulder dystocia during delivery Labor and Delivery (approximately 12 hours)
Secondary Rupture of membranes Presence of rupture of membranes after ECV procedure Within 1 hour of ECV procedure
Secondary Emergency cesarean delivery Need for emergency cesarean delivery during or after ECV procedure During or within 1 hour of performing ECV procedure
Secondary Pelvic hematoma Development of a pelvic hematoma within 1 hour of ECV procedure During or within 1 hour of performing ECV procedure
Secondary Procedural pain Visual analogue pain score prior to during and after ECV procedure (100mm visual analogue scale where 0 =no pain and 10=extreme pain). Immediately before, during, and within 2 minutes after completing the ECV procedure
Secondary Number of attempts Number of attempted ECV procedures to convert fetus from breech to cephalic presentation During and immediately after ECV procedure
Secondary Cost of hospital stay for ECV procedure Total cost of the hospital stay for the ECV procedure Patient arrival to labor unit for ECV procedure and discharge home (up to 72 hours)
See also
  Status Clinical Trial Phase
Recruiting NCT04579835 - Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
Not yet recruiting NCT01922453 - Music and Sounds for ECV N/A
Completed NCT00516555 - EBIS: The Eindhoven Breech Intervention Study N/A
Completed NCT01487590 - Cephalic Version by Acupuncture-Moxibustion for Breech Presentation N/A
Completed NCT00890474 - Moxibustion for Fetus in Breech Presentation Phase 3
Terminated NCT00119184 - Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version Phase 1
Completed NCT05827627 - Simulation Techniques Used in Breech Birth Management Training N/A
Recruiting NCT02801201 - Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation Phase 3
Completed NCT02331160 - Rebozo and External Cephalic Version in Breech Presentation. N/A
Completed NCT00896311 - Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women N/A
Completed NCT00901758 - Intravenous (IV) Nitroglycerin for Versions in Multiparous Women N/A
Not yet recruiting NCT02167841 - Comparison of Efficiency Between Practicing of Knee Chest Position and External Cephalic Version in Cases of Breech Presentation. N/A
Completed NCT01048398 - Remifentanil Versus Paracetamol for Pain Treatment External Cephalic Versions. Phase 3
Recruiting NCT04613778 - Correction of Breech Presentation With Laser Acupuncture N/A
Completed NCT01708018 - Effects of Relaxing Hydrotherapy in Third Trimester of Pregnancy N/A
Terminated NCT00465712 - Effect of Amnioinfusion on External Cephalic Version Successful Rate N/A
Recruiting NCT03827226 - Breech External Cephalic Version Intervention Trial
Completed NCT00813683 - Cephalic Version by Acupuncture for Breech Presentation N/A
Recruiting NCT06187948 - An Informative Video Before Planned External Cephalic Version N/A
Completed NCT00141687 - Early External Cephalic Version (ECV) 2 Trial N/A